Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119856 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL120122 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL20853080 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL27771224 | 0.98 | FAAH (0.40) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL486953 | 0.95 | ALDH1A1 (0.38) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL486954 | 0.95 | ALDH1A1 (0.38) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL486952 | 0.95 | ALDH1A1 (0.38) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL9278970 | 0.94 | FAAH (0.39) | ALDH1A1TSHRFAAHTRPV1MGLL | |
| SCHEMBL2421570 | 0.93 | FAAH (0.34) | ALDH1A1TSHRFAAHMGLL | |
| SCHEMBL2421576 | 0.93 | FAAH (0.34) | ALDH1A1TSHRFAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4435080-B1 | A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE | PROCTER & GAMBLE (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12371642-B2 | Benefit agent containing delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-29 | — | — | US | disclosed |
| EP-3955900-B1 | POLYMERIC CAPSULES | PROCTER & GAMBLE (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| US-20240316523-A1 | PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE | PROCTER & GAMBLE COMPANY, THE | 2024-09-26 | — | — | US | disclosed |
| EP-4435080-A1 | A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE | The Procter & Gamble Company (US) | 2024-09-25 | — | — | EP | disclosed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-3596192-B1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE SLURRIES | PROCTER & GAMBLE (US) | 2024-05-15 | — | — | EP | disclosed |
| US-20230313084-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2023-10-05 | — | — | US | disclosed |
| EP-3664900-B1 | PHOTOSENSITIVE MICROCAPSULES | PROCTER & GAMBLE INT OPERATIONS SA (CH) | 2023-08-23 | — | — | EP | disclosed |
| US-8759275-B2 | High-efficiency perfume capsules | THE PROCTOR & GAMBLE COMPANY (US) | 2014-06-24 | — | — | US | disclosed |
| US-20130316937-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-11-28 | — | — | US | disclosed |
| EP-2468239-B1 | Encapsulates | PROCTER & GAMBLE INTERNAT OPERATIONS SA (CH) | 2013-09-18 | — | — | EP | disclosed |
| US-8524650-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2013-09-03 | — | — | US | disclosed |
| US-20130039962-A1 | ENCAPSULATES | ENCAPSYS, LLC | 2013-02-14 | — | — | US | disclosed |
| EP-2468239-A1 | Encapsulates | Procter & Gamble International Operations SA (CH) | 2012-06-27 | — | — | EP | disclosed |
| US-20120152268-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2012-06-21 | — | — | US | disclosed |
| US-20110152147-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2011-06-23 | — | — | US | disclosed |
| US-20110152146-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY | 2011-06-23 | — | — | US | disclosed |
| US-20110111999-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | THE PROCTER & GAMBLE COMPANY | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039962-A1 | ENCAPSULATES | ABCB4, PPIB, FLNB | ALDH1A1 696/4885TSHR 4882/4885FAAH 384/4885 |
| US-20110111999-A1 | HIGH-EFFICIENCY PERFUME CAPSULES | PLIN5, PORCN, PIGS | ALDH1A1 3767/4885TSHR 4659/4885FAAH 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.